FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:65-67 July 4, 2002 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Davidson, R. PubMed Citation

To the Editor: Davidson et al. (March 7 issue)¹ describe four patients with pneumococcal pneumonia in whom therapy with oral levofloxacin failed. We report on a patient with pneumococcal pneumonia and bacteremia in whom meningitis and sepsis developed after an initial clinical response to levofloxacin therapy.

A 79-year-old man was admitted to Saint Elizabeth's Medical Center in Boston in January 1999 with fever, dyspnea, and left-lower-lobe pneumonia. Treatment with intravenous levofloxacin was started, and the fever resolved. Blood cultures grew Streptococcus pneumoniae, which was sensitive to ceftriaxone, with intermediate resistance to penicillin. Treatment was switched to oral levofloxacin on the . . . [Full Text of this Article]

This article has been cited by other articles:

• Varon, E., Houssaye, S., Grondin, S., Gutmann, L., the Groupe des Observatoires de la Resistance du P, (2006). Nonmolecular Test for Detection of Low-Level Resistance to Fluoroquinolones in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 50: 572-579 [Abstract] [Full Text]  
• Croisier, D., Etienne, M., Bergoin, E., Charles, P.-E., Lequeu, C., Piroth, L., Portier, H., Chavanet, P. (2004). Mutant Selection Window in Levofloxacin and Moxifloxacin Treatments of Experimental Pneumococcal Pneumonia in a Rabbit Model of Human Therapy. Antimicrob. Agents Chemother. 48: 1699-1707 [Abstract] [Full Text]  
• Florea, N. R., Tessier, P. R., Zhang, C., Nightingale, C. H., Nicolau, D. P. (2004). Pharmacodynamics of Moxifloxacin and Levofloxacin at Simulated Epithelial Lining Fluid Drug Concentrations against Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48: 1215-1221 [Abstract] [Full Text]  
• Zhanel, G. G, Noreddin, A. M (2003). Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates: In Vitro Models. The Annals of Pharmacotherapy 37: 1331-1334 [Full Text]